|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2004-8-3
|
|
pubmed:abstractText |
Alveolar hypoxia causes pulmonary hypertension and enhanced right ventricular afterload, which may impair exercise tolerance. The phosphodiesterase-5 inhibitor sildenafil has been reported to cause pulmonary vasodilatation.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1539-3704
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
3
|
|
pubmed:volume |
141
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
169-77
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15289213-3',5'-Cyclic-GMP Phosphodiesterases,
pubmed-meshheading:15289213-Altitude,
pubmed-meshheading:15289213-Anoxia,
pubmed-meshheading:15289213-Blood Pressure,
pubmed-meshheading:15289213-Cardiac Output,
pubmed-meshheading:15289213-Cross-Over Studies,
pubmed-meshheading:15289213-Double-Blind Method,
pubmed-meshheading:15289213-Exercise Tolerance,
pubmed-meshheading:15289213-Female,
pubmed-meshheading:15289213-Humans,
pubmed-meshheading:15289213-Hypertension, Pulmonary,
pubmed-meshheading:15289213-Male,
pubmed-meshheading:15289213-Oxygen,
pubmed-meshheading:15289213-Phosphodiesterase Inhibitors,
pubmed-meshheading:15289213-Piperazines,
pubmed-meshheading:15289213-Placebos,
pubmed-meshheading:15289213-Pulmonary Artery,
pubmed-meshheading:15289213-Purines,
pubmed-meshheading:15289213-Sulfones,
pubmed-meshheading:15289213-Vasodilator Agents
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial.
|
|
pubmed:affiliation |
University Hospital Giessen and Justus-Liebig University, Giessen, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
